Perbedaan Multi Spunindo Jaya Tbk. dan Organon Pharma Indonesia Tbk.: Multi Spunindo Jaya Tbk. diperdagangkan di Rp825 (kapitalisasi pasar 5,24 T, volume 24 jam 16,9 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Multi Spunindo Jaya Tbk. jauh lebih besar — sekitar 50,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MSJA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 5,24 T | 104,4 M |
Volume | 16,9 jt | — |
Lot | 169,01 rb | — |
Perputaran | 13,99 M | — |
Harga Rata-rata | 827,58 | — |
Nilai Transaksi | 13,99 M | — |
Harga Ekuilibrium Indikatif | 825 | — |
Volume Ekuilibrium Indikatif | 1,8 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Multi Spunindo Jaya Tbk (the Company), was established based on Notarial Deed of WahyudiSuyanto, S.H., No. 102 dated March 7, 1997. The Company started its commercial operation in 1999. The Company’s immediate parent company is PT Maju Selaras Jayamerta and the ultimate controlling shareholder of the Company is Sasongko Basuki.
Selengkapnya di halaman MSJA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →